Diabetes Pro Quarterly - Fall 2019 - 6

80TH SCIENTIFIC SESSIONS NEWS

The Scientific Sessions (#ADA2020) Heads to Chicago!
Mark your calendars now for the
world's largest meeting on diabetes-
the American Diabetes Association's
(ADA's) 80th Scientific Sessions.
Next year's meeting will be held June
12-16, 2020, at the McCormick Place
Convention Center in Chicago, IL.
The Scientific Sessions offers researchers
and health care professionals an amazing opportunity to share ideas and learn
about significant advances in diabetes
research, treatment, and care. Over
the course of five days, attendees will
receive exclusive access to more than
2,800 original research presentations,
take part in provocative and engaging
exchanges with leading diabetes experts,
and expand professional networks with
colleagues from around the world.
The program will start on Friday, June
12, 2020, at 11:30 a.m. and conclude on
Tuesday, June 16, 2020, at 12:15 p.m.

Program Development
The overall philosophy of the Scientific
Sessions is to present research and opinions that are not heard at other meetings
and conferences held throughout the
year. The Scientific Sessions Meeting
Planning Committee develops, plans,
and assesses the educational content
of the meeting. Its members provide
professional education opportunities
designed to meet the needs of the ADA's
diverse membership and constituencies
and provide comprehensive leadership
and oversight of the scientific program to
ensure that the meeting meets or exceeds
the quality criteria set forth by the ADA.
Visit scientificsessions.diabetes.org later
this month for more information about
the exciting sessions being developed for
the 2020 program.
6

The 2020 Scientific Sessions Meeting
Planning Committee includes the following members.

Thomas W. Gardner, MD, MS
University of Michigan Kellogg Eye Center
Ann Arbor, MI

Jose C. Florez, MD, PhD (Chair)
Massachusetts General Hospital
Boston, MA

Hertzel C. Gerstein, MD, MSc, FRCPC
McMaster University
Hamilton, Ontario, Canada

Laura C. Alonso, MD
Weill Cornell Medicine
New York, NY

Michael J. Haller, MD, MS-CI
University of Florida
Gainesville, FL

Stephanie A. Amiel, BSc, MD, FRCP
King's College London
London, United Kingdom

Michael A. Harris, PhD
Oregon Health & Science University
Portland, OR

Jamy D. Ard, MD
Wake Forest School of Medicine
Winston-Salem, NC

William H. Herman, MD, MPH
University of Michigan
Ann Arbor, MI

Rita Basu, MD
University of Virginia School of Medicine
Charlottesville, VA

Andrea L. Hevener, PhD
University of California, Los Angeles
Los Angeles, CA

Andrew J.M. Boulton, MD, DSc (Hon),
FACP, FICP, FRCP
Manchester Royal Infirmary
Manchester, United Kingdom

Crystal Holmes, DPM, CWSP
University of Michigan Medical School
Ann Arbor, MI

Luiza Caramori, MD, MSc, PhD
University of Minnesota
Minneapolis, MN

Rebecca L. Hull Meichle, PhD
VA Puget Sound Health Care System
University of Washington
Seattle, WA 

Sheri Colberg, PhD, FACSM
Old Dominion University
Norfolk, VA

Jane K. Kadohiro, DrPH, APRN, CDE,
FAADE
Sparks, NV

Dana Dabelea, MD, PhD
Colorado School of Public Health
Aurora, CO

Sanjay Kaul, MD, FACC, FAHA
Cedars-Sinai Medical Center
Los Angeles, CA

Carmella Evans-Molina, MD, PhD
Indiana University School of Medicine
Indianapolis, IN

Lawrence A. Leiter, MD, FRCPC, FACP,
FACE, FAHA, FACC
St. Michael's Hospital and University of
Toronto
Toronto, Ontario, Canada

Alison Evert, MS, RD, CDE
University of Washington Neighborhood
Clinics
Seattle, WA
Kenneth Feingold, MD
University of California, San Francisco
San Francisco, CA

Jiandie Lin, PhD
University of Michigan
Ann Arbor, MI
continued on page 7
http://scientificsessions.diabetes.org
Diabetes Pro Quarterly - Fall 2019

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Fall 2019
